Pyrrobutamine
Clinical data | |
---|---|
ATC code | R06AX08 (WHO) |
Identifiers | |
| |
CAS Number | 91-82-7 Y |
PubChem (CID) | 5284614 |
ChemSpider | 4447659 N |
UNII | VE6KP18S8X Y |
ChEMBL | CHEMBL1697849 N |
ECHA InfoCard | 100.001.911 |
Chemical and physical data | |
Formula | C20H22ClN |
Molar mass | 311.848 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
NY (what is this?) (verify) |
Pyrrobutamine is an antihistamine and anticholinergic.[1]
References
Aminoalkyl ethers |
|
---|---|
Substituted alkylamines | |
Substituted ethylenediamines |
|
Phenothiazine derivatives | |
Piperazine derivatives | |
Others for systemic use |
|
For topical use |
Receptor (ligands) |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transporter (inhibitors) |
| ||||||||||||||
Enzyme (inhibitors) |
| ||||||||||||||
Others |
|
This article is issued from Wikipedia - version of the 8/27/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.